Epizyme, Inc. (EPZM): Price and Financial Metrics
Epizyme, Inc. (EPZM)
Today's Latest Price: $11.94 USD
0.21 (1.79%)
Updated Sep 25 4:00pm
Add EPZM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
EPZM Stock Summary
- With a price/sales ratio of 87.61, Epizyme Inc has a higher such ratio than 97.03% of stocks in our set.
- With a year-over-year growth in debt of 731.59%, Epizyme Inc's debt growth rate surpasses 97.34% of about US stocks.
- Revenue growth over the past 12 months for Epizyme Inc comes in at -41.13%, a number that bests only 5.46% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Epizyme Inc, a group of peers worth examining would be CTIC, HTBX, BCYC, DSPG, and QUIK.
- Visit EPZM's SEC page to see the company's official filings. To visit the company's web site, go to www.epizyme.com.
EPZM Daily Price Range
EPZM 52-Week Price Range
EPZM Stock Price Chart Technical Analysis Charts
EPZM Price/Volume Stats
| Current price | $11.94 | 52-week high | $27.82 |
| Prev. close | $11.73 | 52-week low | $9.73 |
| Day low | $11.61 | Volume | 737,006 |
| Day high | $12.10 | Avg. volume | 1,069,074 |
| 50-day MA | $13.03 | Dividend yield | N/A |
| 200-day MA | $17.68 | Market Cap | 1.21B |
Epizyme, Inc. (EPZM) Company Bio
Epizyme, Inc. discovers and develops epigenetic therapies for cancer patients. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...